SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
CC
Lv3
296 积分
2022-10-22 加入
最近求助
最近应助
互助留言
Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial
8小时前
待确认
Chemerin is a key player in antimicrobial defense in skin
1个月前
已完结
Resolvin E1 (RX-10001) Reduces Corneal Epithelial Barrier Disruption and Protects Against Goblet Cell Loss in a Murine Model of Dry Eye
1个月前
已完结
The role of chemerin in human disease
2个月前
已完结
Alpha-NETA, as a CMKLR1 Small Molecule Antagonist, Protects against Renal Ischemia Reperfusion Injury in Mice
2个月前
已完结
Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors
2个月前
已完结
Macrophages in Lung Repair and Fibrosis
3个月前
已完结
Efficacy and safety of efdamrofusp alfa versus aflibercept in participants with neovascular age-related macular degeneration: a randomized, double-masked, active-controlled, non-inferiority, phase 2 trial
7个月前
已完结
PIM‐1L Kinase Binds to and Inactivates SRPK1: A Biochemical and Molecular Dynamics Study
7个月前
已完结
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease
8个月前
已完结
First real-world clinical experience with [177Lu]Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer beyond VISION and TheraP criteria
3个月前
已采纳
感谢
2个月前
感谢
2个月前
感谢
8个月前
感谢
9个月前
感谢
9个月前
感谢
9个月前
已找到【积分已退回】
1年前
感谢
2年前
感谢
2年前
感谢
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论